FYB/ADAP/SLAP130 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-26103
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Bovine (100%), Canine (100%). Backed by our 100% Guarantee.
Applications
Peptide ELISA, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Goat IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Peptide with sequence C-SEEKPDKEPKP corresponding to internal region according to NP_001456.3, NP_955367.1, NP_001230022.1.
Specificity
This antibody is expected to recognise all reported isoforms (NP_001456.3; NP_955367.1; NP_001230022.1).
Clonality
Polyclonal
Host
Goat
Isotype
IgG
Scientific Data Images for FYB/ADAP/SLAP130 Antibody
Western Blot: FYB/ADAP/SLAP130 Antibody [NBP2-26103]
Western Blot: FYB/ADAP/SLAP130 Antibody [NBP2-26103] - Staining of MOLT4 lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.Applications for FYB/ADAP/SLAP130 Antibody
Application
Recommended Usage
Peptide ELISA
Detection limit 1:2000
Western Blot
0.2 - 0.6 ug/ml
Application Notes
WB: Approx. 90 kDa band observed in MOLT4 lysates (calculated MW of 90.6 kDa band according to NP_001456.3).
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
Preservative
0.02% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: FYB/ADAP/SLAP130
Long Name
FYN Binding Protein (FYB-120/130)
Alternate Names
ADAP, PRO0823, SLAP130
Entrez Gene IDs
2533 (Human)
Gene Symbol
FYB1
Additional FYB/ADAP/SLAP130 Products
Product Documents for FYB/ADAP/SLAP130 Antibody
Product Specific Notices for FYB/ADAP/SLAP130 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...